NEET MDS Lessons
Public Health Dentistry
Factors Considered for Prescribing Fluoride Tablets
Child's Age:
- Different age groups require different dosages.
- Children older than 4 years may receive lozenges or chewable tablets, while those younger than 4 are typically prescribed liquid fluoride drops.
Fluoride Concentration in Drinking Water:
- The fluoride level in the child's drinking water is crucial.
- If the fluoride concentration is less than 1 part per million (ppm), systemic fluoride supplementation is recommended.
Risk of Dental Caries:
- Children at higher risk for dental decay may need additional fluoride supplementation.
- Regular dental assessments help determine the need for fluoride.
Overall Health and Dietary Needs:
- Consideration of the child's overall health and any dietary restrictions that may affect fluoride intake.
Recommended Doses of Fluoride Tablets
For Children Aged 6 Months to 4 Years:
- Liquid drops are typically prescribed in doses of 0.125, 0.25, and 0.5 mg of fluoride ion.
For Children Aged 4 Years and Older:
- Chewable tablets or lozenges are recommended, usually at doses of 0.5 mg to 1 mg of fluoride ion.
Adjustments Based on Water Fluoride Levels:
- Doses may be adjusted based on the fluoride content in the child's drinking water to ensure adequate protection against dental caries.
Duration of Supplementation:
- Fluoride supplementation is generally continued until the child reaches 16 years of age, depending on their fluoride exposure and dental health status.
Classifications of epidemiologic research
1. Descriptive research —involves description, documentation, analysis, and interpretation of data to evaluate a current event or situation
a. incidence—number of new cases of a specific disease within a defined population over a period of time
b. Prevalence—number of persons in a population affected by a condition at any one time
c. Count—simplest sum of disease: number of cases of disease occurrence
d. Proportion—use of a count with the addition of a denominator to determine prevalence:
does not include a time dimension: useful to evaluate prevalence of caries in schoolchildren or tooth loss in adult populations
e. Rate— uses a standardized denominator and includes a time dimension. for example. the number of deaths of newborn infants within first year of life per 1000 births
2. Analytical research—determines the cause of disease or if a causal relationship exists between a factor and a disease
a. Prospective study—planning of the entire study is completed before data are collected and analyzed; population is followed through time to determine which members develop the disease; several hypotheses may be tested at on time
b. Cohort study—individuals are classified into groups according to whether or not they pos- sess a particular characteristic thought to be related to the condition of interest; observations occur over time to see who develops dis ease or condition
c. Retrospective study— decision to carry out an investigation using observations or data that have been collected in the past; data may be incomplete or in a manner not appropriate for study
d. Cross-sectional study— study of subgroups of individuals in a specific and limited time frame to identify either initially to describe current status or developmental changes in the overall group from the perspective of what is typical in each subgroup
e. Longitudinal study—investigation of the same group of individuals over an extended period of time to identify a change or devel opment in that group
3. Experimental research—used when the etiology of the disease is established and the researcher wishes to determine the effectiveness of altering some factor or factors; deliberate applying or withholding of the supposed cause of a condition and observing the result
Plaque index (PlI)
0 = No plaque in the gingival area.
1 = A thin film of plaque adhering to the free gingival margin and adjacent to the area of the tooth. The plaque is not readily visible, but is recognized by running a periodontal probe across the tooth surface.
2 = Moderate accumulation of plaque on the gingival margin, within the gingival pocket, and/or adjacent to the tooth surface, which can be observed visually.
3 = Abundance of soft matter within the gingival pocket and/or adjacent to the tooth surface.
Gingival index (GI)
0 = Healthy gingiva.
1= Mild inflammation: characterized by a slight change in color, edema. No bleeding observed on gentle probing.
2 = Moderate inflammation: characterized by redness, edema, and glazing. Bleeding on probing observed.
3 = Severe inflammation: characterized by marked redness and edema. Ulceration with a tendency toward spontaneous bleeding.
Modified gingival index (MGI)
0 = Absence of inflammation.
1 = Mild inflammation: characterized by a slight change in texture of any portion of, but not the entire marginal or papillary gingival unit.
2 = Mild inflammation: criteria as above, but involving the entire marginal or papillary gingival unit.
3 = Moderate inflammation: characterized by glazing, redness, edema, and/or hypertrophy of the marginal or papillary gingival unit.
4 = Severe inflammation: marked redness, edema, and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, or ulceration.
Community periodontal index (CPI)
0 = Healthy gingiva.
1 = Bleeding observed after gentle probing or by visualization.
2 = Calculus felt during probing, but all of the black area of the probe remains visible (3.5-5.5 mm from ball tip).
3 = Pocket 4 or 5 mm (gingival margin situated on black area of probe, approximately 3.5-5.5 mm from the probe tip).
4 = Pocket > 6 mm (black area of probe is not visible).
Periodontal screening and recording (PSR)
0 = Healthy gingiva. Colored area of the probe remains visible, and no evidence of calculus or defective margins is detected.
1 = Colored area of the probe remains visible and no evidence of calculus or defective margins is detected, but bleeding on probing is noted.
2 = Colored area of the probe remains visible and calculus or defective margins is detected.
3 = Colored area of the probe remains partly visible (probe depth between 3.5-5.5 mm).
4 = Colored area of the probe completely disappears (probe depth > 5.5 mm).
Berkson's Bias is a type of selection bias that occurs in case-control studies, particularly when the cases and controls are selected from a hospital or clinical setting. It arises when the selection of cases (individuals with the disease) and controls (individuals without the disease) is influenced by the presence of other conditions or factors, leading to a distortion in the association between exposure and outcome.
Key Features of Berkson's Bias
-
Hospital-Based Selection: Berkson's Bias typically occurs in studies where both cases and controls are drawn from the same hospital or clinical setting. This can lead to a situation where the controls are not representative of the general population.
-
Association with Other Conditions: Individuals who are hospitalized may have multiple health issues or risk factors that are not present in the general population. This can create a misleading association between the exposure being studied and the disease outcome.
-
Underestimation or Overestimation of Risk: Because the controls may have different health profiles compared to the general population, the odds ratio calculated in the study may be biased. This can lead to either an overestimation or underestimation of the true association between the exposure and the disease.
Example of Berkson's Bias
Consider a study investigating the relationship between smoking and lung cancer, where both cases (lung cancer patients) and controls (patients without lung cancer) are selected from a hospital. If the controls are patients with other diseases that are also related to smoking (e.g., chronic obstructive pulmonary disease), this could lead to Berkson's Bias. The controls may have a higher prevalence of smoking than the general population, which could distort the perceived association between smoking and lung cancer.
Implications of Berkson's Bias
- Misleading Conclusions: Berkson's Bias can lead researchers to draw incorrect conclusions about the relationship between exposures and outcomes, which can affect public health recommendations and clinical practices.
- Generalizability Issues: Findings from studies affected by Berkson's Bias may not be generalizable to the broader population, limiting the applicability of the results.
Mitigating Berkson's Bias
To reduce the risk of Berkson's Bias in research, researchers can:
-
Select Controls from the General Population: Instead of selecting controls from a hospital, researchers can use population-based controls to ensure a more representative sample.
-
Use Multiple Control Groups: Employing different control groups can help identify and account for potential biases.
-
Stratify Analyses: Stratifying analyses based on relevant characteristics (e.g., age, sex, comorbidities) can help to control for confounding factors.
-
Conduct Sensitivity Analyses: Performing sensitivity analyses can help assess how robust the findings are to different assumptions about the data.
A test of significance in dentistry, as in other fields of research, is a
statistical method used to determine whether observed results are likely due to
chance or if they are statistically significant, meaning that they are reliable
and not random. It helps dentists and researchers make inferences about the
validity of their hypotheses.
The procedure for conducting a test of significance typically involves the
following steps:
1. Formulate a Null Hypothesis (H0) and an Alternative Hypothesis (H1):
The null hypothesis is a statement that assumes there is no significant
difference between groups or variables being studied, while the alternative
hypothesis suggests that there is a significant difference. For example, in a
dental study comparing two different toothpaste brands for their effectiveness
in reducing plaque, the null hypothesis might be that there is no difference in
plaque reduction between the two brands, while the alternative hypothesis would
be that one brand is more effective than the other.
2. Choose a significance level (α): This is the probability of
incorrectly rejecting the null hypothesis when it is true. Common significance
levels are 0.05 (5%) or 0.01 (1%).
3. Determine the sample size: Depending on the research
question, power analysis or literature review may help determine the appropriate
sample size needed to detect a clinically significant difference.
4. Collect data: Gather data from a sample of patients or
subjects under controlled conditions or from existing databases.
5. Calculate test statistics: This involves calculating a value
that represents the magnitude of the difference between the observed data and
what would be expected if the null hypothesis were true. Common test statistics
include the t-test, chi-square test, and ANOVA (Analysis of Variance).
6. Determine the p-value: The p-value is the probability of
obtaining the observed results or results more extreme than those observed if
the null hypothesis were true. It is calculated based on the test statistic and
the chosen significance level.
7. Compare the p-value to the significance level (α): If the
p-value is less than the significance level, the result is considered
statistically significant. If the p-value is greater than the significance
level, the result is not statistically significant, and the null hypothesis is
not rejected.
8. Interpret the results: Based on the p-value, make a decision
about the null hypothesis. If the p-value is less than the significance level,
reject the null hypothesis and accept the alternative hypothesis. If the p-value
is greater than the significance level, fail to reject the null hypothesis.
Here is a simplified example of a test of significance applied to dentistry:
Suppose you are comparing two different toothpaste brands to determine if there
is a significant difference in their effectiveness in reducing dental plaque.
You conduct a study with 50 participants who are randomly assigned to use either
brand A or brand B for a month. After a month, you measure the plaque levels of
all participants.
1. Null Hypothesis (H0): There is no significant difference in plaque reduction
between the two toothpaste brands.
2. Alternative Hypothesis (H1): There is a significant difference in plaque
reduction between the two toothpaste brands.
3. Significance Level (α): 0.05
Now, let's say you collected the data and found that the mean plaque reduction
for brand A was 25%, with a standard deviation of 5%, and for brand B, the mean
was 30%, with a standard deviation of 4%. You could use an independent samples
t-test to compare the two groups' means.
4. Calculate the t-statistic: t = (Mean of Brand B - Mean of Brand A) /
(Standard Error of the Difference)
5. Find the p-value associated with the calculated t-statistic. If the p-value
is less than 0.05, you reject the null hypothesis.
If the p-value is less than 0.05, you can conclude that there is a statistically
significant difference in plaque reduction between the two toothpaste brands,
supporting the alternative hypothesis that one brand is more effective than the
other. This could lead to further research or a change in dental hygiene
recommendations.
In dental applications, tests of significance are commonly used in studies
examining the effectiveness of different treatments, materials, and procedures.
For instance, they can be applied to compare the success rates of different
types of dental implants, the efficacy of various tooth whitening methods, or
the impact of oral hygiene interventions on periodontal health. Understanding
the statistical significance of these findings allows dentists to make
evidence-based decisions and recommendations for patient care.
Case-Control Study and Cohort Study are two types of epidemiological studies
commonly used in dental research to identify potential risk factors and
understand the causality of diseases or conditions.
1. Case-Control Study:
A case-control study is a retrospective analytical study design in which
researchers start with a group of patients who already have the condition of
interest (the cases) and a group of patients without the condition (the
controls) and then work backward to determine if the cases and controls have
different exposures to potential risk factors. It is often used when the
condition is relatively rare, when it takes a long time to develop, or when it
is difficult to follow individuals over time.
In a case-control study, the cases are selected from a population that already
has the disease or condition being studied. The controls are selected from the
same population but do not have the disease. The researchers then compare the
two groups to see if there is a statistically significant difference in the
frequency of exposure to a particular risk factor.
Example in Dentistry:
Suppose we want to investigate whether there is a link between periodontal
disease and cardiovascular disease. A case-control study might be set up as
follows:
- Cases: Patients with a diagnosis of periodontal disease.
- Controls: Patients without a diagnosis of periodontal disease but otherwise
similar to the cases (same age, gender, socioeconomic status, etc.).
- Exposure of Interest: Cardiovascular disease.
The researchers would collect data on the medical and dental histories of both
groups, looking for a history of cardiovascular disease. They would compare the
proportion of cases with a history of cardiovascular disease to the proportion
of controls with the same history. If a significantly higher proportion of cases
have a history of cardiovascular disease, this suggests that there may be an
association between periodontal disease and cardiovascular disease. However,
because the study is retrospective, it does not prove that periodontal disease
causes cardiovascular disease. It merely suggests that the two are associated.
Advanatages:
- Efficient for studying rare diseases.
- Relatively quick and inexpensive.
- Can be used to identify multiple risk factors for a condition.
- Useful for generating hypotheses for further research.
Disadvantages:
- Can be prone to selection and recall bias.
- Cannot determine the temporal sequence of exposure and outcome.
- Cannot calculate the incidence rate or the absolute risk of developing the
disease.
- Odds ratios may not accurately reflect the relative risk in the population if
the disease is not rare.
2. Cohort Study:
A cohort study is a prospective longitudinal study that follows a group of
individuals (the cohort) over time to determine if exposure to specific risk
factors is associated with the development of a particular disease or condition.
Cohort studies are particularly useful in assessing the risk factors for
diseases that take a long time to develop or when the exposure is rare.
In a cohort study, participants are recruited and categorized based on their
exposure to a particular risk factor (exposed and non-exposed groups). The
researchers then follow these groups over time to see who develops the disease
or condition of interest.
Example in Dentistry:
Let's consider the same hypothesis as before, but this time using a cohort study
design:
- Cohort: A group of individuals who are initially free of
cardiovascular disease, but some have periodontal disease (exposed) and others
do not (non-exposed).
- Follow-up: Researchers would follow this cohort over a
certain period (e.g., 10 years).
- Outcome Measure: Incidence of new cases of cardiovascular
disease.
The researchers would track the incidence of cardiovascular disease in both
groups and compare the rates. If the exposed group (those with periodontal
disease) has a higher rate of developing cardiovascular disease than the
non-exposed group (those without periodontal disease), this would suggest that
periodontal disease may be a risk factor for cardiovascular disease.
Advanatges:
- Allows for the calculation of incidence rates.
- Can determine the temporal relationship between exposure and outcome.
- Can be used to study the natural history of a disease.
- Can assess multiple outcomes related to a single exposure.
- Less prone to recall bias since exposure is assessed before the outcome
occurs.
Disdvanatges:
- Can be expensive and time-consuming.
- Can be difficult to maintain participant follow-up, leading to loss to
follow-up bias.
- Rare outcomes may require large cohorts and long follow-up periods.
- Can be affected by confounding variables if not properly controlled for.
Both case-control and cohort studies are valuable tools in dental research.
Case-control studies are retrospective, quicker, and less costly, but
may be limited by biases. Cohort studies are prospective, more robust for
establishing causal relationships, but are more resource-intensive and require
longer follow-up periods. The choice of study design depends on the
research question, the availability of resources, and the nature of the disease
or condition being studied.
Importance of Behavior Management in Geriatric Patients with
Cognitive Impairment:
1. Safety and Comfort: Cognitive impairments such as dementia or Alzheimer's
disease can lead to fear, confusion, and aggression, which may increase the risk
of injury to the patient or the dental team. Proper behavior management
techniques ensure a calm and cooperative environment, minimizing the risk of
harm.
2. Effective Communication: Patients with cognitive impairments often have
difficulty understanding and following instructions, which can lead to poor
treatment outcomes if not managed effectively. Careful and empathetic
communication is essential for successful treatment.
3. Patient Cooperation: Engaging and reassuring patients can enhance their
willingness to participate in the dental care process, which is critical for
accurate diagnosis and treatment planning.
4. Maintenance of Dignity and Autonomy: Patients with cognitive impairments are
particularly vulnerable to losing their sense of self-worth. Sensitive behavior
management strategies can help maintain their dignity and allow them to make
informed decisions as much as possible.
Challenges in Treating Geriatric Patients with Cognitive Impairment:
- Memory Loss: Patients may forget why they are at the dental office, what
procedures were done, or instructions given, necessitating repetition and
patience.
- Language and Comprehension Difficulties: They may struggle to understand
questions or instructions, making communication challenging.
- Behavioral and Psychological Symptoms of Dementia (BPSD): These include
agitation, aggression, depression, and anxiety, which can complicate the
delivery of care.
- Physical Limitations: Cognitive impairments often coexist with physical
disabilities, which may necessitate specialized approaches for positioning,
providing care, and ensuring patient comfort.
- Medication Side Effects: Drugs used to manage cognitive symptoms can cause
xerostomia, increased risk of caries, and other oral health issues that require
careful consideration during treatment.
Strategies for Behavior Management:
1. Pre-Appointment Preparation: Involve caregivers in the appointment planning
process, obtaining medical histories, and preparing patients for what to expect
during the visit.
2. Environmental Modification: Create a calm, familiar, and non-threatening
environment with minimal sensory stimulation, such as using soothing music,
lighting, and comfortable seating.
3. Simplified Communication: Use clear, simple language, speak slowly and loudly
if necessary, and avoid medical jargon.
4. Non-verbal Communication: Employ non-verbal cues, gestures, and visual aids
to support understanding.
5. Building Rapport: Establish trust by introducing oneself, maintaining eye
contact, and using a gentle touch.
6. Recognizing and Addressing Pain: Patients with cognitive impairments may not
be able to communicate pain effectively. Regular assessment and use of pain
management techniques are critical.
7. Pharmacological Interventions: In some cases, short-term or as-needed
medications may be necessary to manage anxiety or agitation, but should be used
judiciously due to potential side effects.
8. Behavioral Interventions: Employ techniques such as distraction, relaxation,
and desensitization to reduce anxiety.
9. Task Simplification: Break down complex procedures into smaller, more
manageable steps.
10. Use of Caregivers: Caregivers can provide comfort, support, and assistance
during appointments, and can help reinforce instructions post-treatment.
11. Consistency and Routine: Maintain a consistent approach and routine during
appointments to reduce confusion.
12. Cognitive Stimulation: Engage patients with familiar objects or topics to
help orient them during the visit.
13. Therapeutic Touch: Use therapeutic touch, such as hand-over-mouth or
hand-over-hand techniques, to guide patients through procedures and build trust.
14. Positive Reinforcement: Reward cooperative behavior with verbal praise,
physical comfort, or small treats if appropriate.
15. Recognizing Triggers: Identify and avoid situations that may lead to
agitation or distress, such as certain sounds or procedures.
16. Education and Training: Ensure that the dental team is well-informed about
cognitive impairments and best practices for behavior management.